Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Pharma Officials Air Hopes and Concerns for New LDP Leader, Eyes on MHLW Revamp
September 30, 2021
-
ORGANIZATION FPMAJ Chief Praises Political Acumen of New LDP Leader Kishida, Seeks Support for Industry
September 30, 2021
-
COMMENTARY 5 Companies Developing Japan-Made COVID-19 Jabs Face Challenges in Subject Enrollment, Trial Designs
September 29, 2021
-
BUSINESS Shionogi Kicks Off Japan PII/III Trial for Oral COVID-19 Drug
September 29, 2021
-
REGULATORY Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
September 28, 2021
-
REGULATORY Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
September 28, 2021
-
ORGANIZATION Chuikyo Payer Rep Wants to Cut into Cost-Based Method, Adjustment Rate, Off-Year Revision in FY2022 Reform, Eyes Special Rules for Aducanumab
September 27, 2021
-
BUSINESS Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
September 27, 2021
-
REGULATORY One-Month Business Suspension Order Likely for Choseido over Generic Recalls
September 24, 2021
-
BUSINESS Shionogi to Begin PII/III Study for Oral COVID-19 Drug on Sept. 27: President
September 24, 2021
-
BUSINESS Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III
September 24, 2021
-
ORGANIZATION JPMA Chief Opposes Macroeconomic Indexing, Says Drugs Should Drive Economic Growth
September 22, 2021
-
REGULATORY GSK/Vir’s COVID-19 Drug Up for MHLW Panel Review on Sept. 27
September 22, 2021
-
BUSINESS New Heart Failure Drugs Jostling with Different Modes of Action, Offering Variety of Options
September 21, 2021
-
REGULATORY All 4 Contenders in LDP Leadership Race Vow to Expand COVID-19 Measures
September 21, 2021
-
REGULATORY Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
-
BUSINESS Sumitomo Dainippon Expects Twymeeg’s Initial Uptake in Combo, but Eyes 1st Line Monotherapy Use Too
September 17, 2021
-
BUSINESS White Matter Found in COVID-19 Vaccine Vials Not Contaminant: Pfizer
September 16, 2021
-
REGULATORY Tainted Moderna Jabs Run Afoul of PMD Law: Minister
September 16, 2021
-
REGULATORY Japan Eyes Legal System to Ensure Generic Supplies in New Industry Vision, Key Official Says It’s Difficult with Companies’ Own Efforts Alone
September 15, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…